We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

198 hedge funds and large institutions have $2.69B invested in Ariad Pharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 198 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more call options, than puts

Call options by funds: $16M | Put options by funds: $15.8M

Holders
198
Holders Change
+198
Holders Change %
–
% of All Funds
6.46%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
198
Increased
–
Reduced
–
Closed
–
Calls
$16M
Puts
$15.8M
Net Calls
+$187K
Net Calls Change
+$187K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$302M +$306M +17,289,316 New
Artisan Partners
2
Artisan Partners
Wisconsin
$171M +$174M +9,798,013 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$169M +$172M +9,690,345 New
Goldman Sachs
4
Goldman Sachs
New York
$115M +$116M +6,568,570 New
Neuberger Berman Group
5
Neuberger Berman Group
New York
$96.6M +$97.9M +5,521,168 New
WRF
6
Waddell & Reed Financial
Kansas
$95.9M +$97.2M +5,484,300 New
SAM
7
Sectoral Asset Management
Quebec, Canada
$92.6M +$93.8M +5,292,682 New
Ameriprise
8
Ameriprise
Minnesota
$91.3M +$92.5M +5,219,297 New
EAM
9
Eagle Asset Management
Florida
$86.4M +$87.5M +4,938,043 New
Franklin Resources
10
Franklin Resources
California
$83.9M +$85.1M +4,798,480 New
BIT
11
BlackRock Institutional Trust
California
$78.9M +$80M +4,510,955 New
JHIU
12
Janus Henderson Investors US
Colorado
$73.4M +$74.4M +4,196,314 New
CWAM
13
Columbia Wanger Asset Management
Illinois
$73M +$74M +4,174,000 New
State Street
14
State Street
Massachusetts
$63.4M +$64.3M +3,627,162 New
TCM
15
TimesSquare Capital Management
New York
$62.9M +$63.7M +3,594,377 New
Federated Hermes
16
Federated Hermes
Pennsylvania
$62.4M +$63.3M +3,568,823 New
BFA
17
BlackRock Fund Advisors
California
$59.4M +$60.2M +3,395,820 New
BB
18
BB Biotech
Switzerland
$54.5M +$55.2M +3,115,371 New
ORI
19
Oak Ridge Investments
Illinois
$46.3M +$46.9M +2,645,781 New
Adage Capital Partners
20
Adage Capital Partners
Massachusetts
$45.8M +$46.5M +2,620,752 New
Jennison Associates
21
Jennison Associates
New York
$38.6M +$39.1M +2,205,987 New
RIM
22
Rainier Investment Management
Washington
$35.7M +$36.2M +2,042,010 New
CLM
23
ClearBridge LLC (Maryland)
Maryland
$30.9M +$31.3M +1,765,204 New
CCI
24
Columbus Circle Investors
$30.1M +$30.5M +1,719,337 New
Invesco
25
Invesco
Georgia
$25.6M +$26M +1,466,115 New
1
2 3 4 5

ARIA Hedge Fund Activity: Q2 2013 in Review

198 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q2 2013, worth a combined $2.69B.

Buyers outnumbered sellers: 198 funds opened new ARIA positions and 0 closed out — a net gain of 198 holders — while 0 added to existing stakes and 0 trimmed.

  • 198 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.69B of Ariad Pharmaceuticals Inc stock for Q2 2013.
  • 198 funds opened new Ariad Pharmaceuticals Inc positions in Q2 2013 and 0 closed out, a net change of +198 holders.

Based on aggregated 13F filings for Q2 2013.